Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/3077
Title: ASSESSMENT OF MAIN LIPID METABOLISM INDICATORS IN PATIENTS WITH CHRONIC PANCREATITIS AND METABOLICALLY ASSOCIATED FATTY LIVER DISEASE
Authors: D FATTY LIVER DISEASE Rakhmatullaeva G. K. Sadullaeva U. A. Abdunazarova Z. A. Tashkent State Medical University
Issue Date: 16-Feb-2026
Abstract: Abstract The prevalence of metabolic syndrome (MS), non-alcoholic fatty liver disease (NAFLD), and non- alcoholic fatty pancreatic disease (NAFPD) accounts for one-quarter to one-third of the world’s population. It has been proven that the key pathogenetic mechanisms of these conditions are disorders of lipid and carbohydrate metabolism. A high comorbidity between NAFLD and NAFPD has been demonstrated: 67.9% of patients with NAFPD were found to have hepatic steatosis, and 96.8% of patients with NAFLD were diagnosed with pancreatic steatosis.
URI: http://repo.tma.uz/xmlui/handle/1/3077
ISSN: 2938-3765
Appears in Collections:

Files in This Item:
File Description SizeFormat 
5.Assessment of main lipid metabolism.pdf390.1 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.